Selected research
Industry Growth & Trends
Global Compounded Topical Drug Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Compounded Topical Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Compounded Topical Drug market include Triangle Compounding Pharmacy, QuVa Pharma, PharMEDium Services, Pharmaca Integrative Pharmacy, Perrigo Company plc, PCCA (Professional Compounding Centers of America), Nephron Pharmaceuticals Corporation, Medisca and Lorraine’s Pharmacy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Compounded Topical Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Compounded Topical Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Compounded Topical Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Compounded Topical Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Compounded Topical Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Compounded Topical Drug Market by Company
Triangle Compounding Pharmacy
QuVa Pharma
PharMEDium Services
Pharmaca Integrative Pharmacy
Perrigo Company plc
PCCA (Professional Compounding Centers of America)
Nephron Pharmaceuticals Corporation
Medisca
Lorraine’s Pharmacy
Institutional Pharmacy Solutions
Fresenius Kabi
Fagron
Custom Scripts Pharmacy
Central Admixture Pharmacy Services (CAPS)
CareFirst Specialty Pharmacy
Cantrell Drug Company
B. Braun Melsungen AG Company
Avella Specialty Pharmacy
Atlas Pharmaceuticals
Compounded Topical Drug Segment by Type
Ointments
Lotions
Cream
Gels
Compounded Topical Drug Segment by Application
Hospitals
Retail Pharmacy
Other
Compounded Topical Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounded Topical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Compounded Topical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounded Topical Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Compounded Topical Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Ointments
- Lotions
- Cream
- Gels
Applications
- Hospitals
- Retail Pharmacy
- Other
Companies covered
- Triangle Compounding Pharmacy
- QuVa Pharma
- PharMEDium Services
- Pharmaca Integrative Pharmacy
- Perrigo Company plc
- PCCA (Professional Compounding Centers of America)
- Nephron Pharmaceuticals Corporation
- Medisca
- Lorraine’s Pharmacy
- Institutional Pharmacy Solutions
- Fresenius Kabi
- Fagron
- Custom Scripts Pharmacy
- Central Admixture Pharmacy Services (CAPS)
- CareFirst Specialty Pharmacy
- Cantrell Drug Company
- B. Braun Melsungen AG Company
- Avella Specialty Pharmacy
- Atlas Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Compounded Topical Drug Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Compounded Topical Drug Market Size by Region (2021-2032)
- 1.4.1 Global Compounded Topical Drug Market Size by Region (2021-2026)
- 1.4.2 Global Compounded Topical Drug Market Size by Region (2027-2032)
- 1.5 Key Regions Compounded Topical Drug Market Size (2021-2032)
- 1.5.1 North America Compounded Topical Drug Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Compounded Topical Drug Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Compounded Topical Drug Market Size Growth Rate (2021-2032)
- 1.5.4 South America Compounded Topical Drug Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Compounded Topical Drug Market Size Growth Rate (2021-2032)
2 Compounded Topical Drug Market by Type
- 2.1 Type Introduction
- 2.1.1 Ointments
- 2.1.2 Lotions
- 2.1.3 Cream
- 2.1.4 Gels
- 2.2 Global Compounded Topical Drug Market Size by Type
- 2.2.1 Global Compounded Topical Drug Market Size Overview by Type (2021-2032)
- 2.2.2 Global Compounded Topical Drug Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Compounded Topical Drug Market Size Forecasted by Type (2027-2032)
- 2.3 Global Compounded Topical Drug Market Size by Regions
- 2.3.1 North America Compounded Topical Drug Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Compounded Topical Drug Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Compounded Topical Drug Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Compounded Topical Drug Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Compounded Topical Drug Market Size Breakdown by Type (2021-2026)
3 Compounded Topical Drug Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Retail Pharmacy
- 3.1.3 Other
- 3.2 Global Compounded Topical Drug Market Size by Application
- 3.2.1 Global Compounded Topical Drug Market Size Overview by Application (2021-2032)
- 3.2.2 Global Compounded Topical Drug Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Compounded Topical Drug Market Size Forecasted by Application (2027-2032)
- 3.3 Global Compounded Topical Drug Market Size by Regions
- 3.3.1 North America Compounded Topical Drug Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Compounded Topical Drug Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Compounded Topical Drug Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Compounded Topical Drug Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Compounded Topical Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Compounded Topical Drug Industry Trends
- 4.2 Compounded Topical Drug Industry Drivers
- 4.3 Compounded Topical Drug Industry Opportunities and Challenges
- 4.4 Compounded Topical Drug Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Compounded Topical Drug Revenue (2021-2026)
- 5.2 Global Compounded Topical Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Compounded Topical Drug Key Company Headquarters & Area Served
- 5.4 Global Compounded Topical Drug Company, Product Type & Application
- 5.5 Global Compounded Topical Drug Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Compounded Topical Drug Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Compounded Topical Drug Players Market Share by Revenue in 2025
- 5.6.3 2025 Compounded Topical Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Triangle Compounding Pharmacy
- 6.1.1 Triangle Compounding Pharmacy Company Information
- 6.1.2 Triangle Compounding Pharmacy Business Overview
- 6.1.3 Triangle Compounding Pharmacy Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio
- 6.1.5 Triangle Compounding Pharmacy Recent Developments
- 6.2 QuVa Pharma
- 6.2.1 QuVa Pharma Company Information
- 6.2.2 QuVa Pharma Business Overview
- 6.2.3 QuVa Pharma Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 QuVa Pharma Compounded Topical Drug Product Portfolio
- 6.2.5 QuVa Pharma Recent Developments
- 6.3 PharMEDium Services
- 6.3.1 PharMEDium Services Company Information
- 6.3.2 PharMEDium Services Business Overview
- 6.3.3 PharMEDium Services Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 PharMEDium Services Compounded Topical Drug Product Portfolio
- 6.3.5 PharMEDium Services Recent Developments
- 6.4 Pharmaca Integrative Pharmacy
- 6.4.1 Pharmaca Integrative Pharmacy Company Information
- 6.4.2 Pharmaca Integrative Pharmacy Business Overview
- 6.4.3 Pharmaca Integrative Pharmacy Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio
- 6.4.5 Pharmaca Integrative Pharmacy Recent Developments
- 6.5 Perrigo Company plc
- 6.5.1 Perrigo Company plc Company Information
- 6.5.2 Perrigo Company plc Business Overview
- 6.5.3 Perrigo Company plc Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Perrigo Company plc Compounded Topical Drug Product Portfolio
- 6.5.5 Perrigo Company plc Recent Developments
- 6.6 PCCA (Professional Compounding Centers of America)
- 6.6.1 PCCA (Professional Compounding Centers of America) Company Information
- 6.6.2 PCCA (Professional Compounding Centers of America) Business Overview
- 6.6.3 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio
- 6.6.5 PCCA (Professional Compounding Centers of America) Recent Developments
- 6.7 Nephron Pharmaceuticals Corporation
- 6.7.1 Nephron Pharmaceuticals Corporation Company Information
- 6.7.2 Nephron Pharmaceuticals Corporation Business Overview
- 6.7.3 Nephron Pharmaceuticals Corporation Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio
- 6.7.5 Nephron Pharmaceuticals Corporation Recent Developments
- 6.8 Medisca
- 6.8.1 Medisca Company Information
- 6.8.2 Medisca Business Overview
- 6.8.3 Medisca Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Medisca Compounded Topical Drug Product Portfolio
- 6.8.5 Medisca Recent Developments
- 6.9 Lorraine’s Pharmacy
- 6.9.1 Lorraine’s Pharmacy Company Information
- 6.9.2 Lorraine’s Pharmacy Business Overview
- 6.9.3 Lorraine’s Pharmacy Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio
- 6.9.5 Lorraine’s Pharmacy Recent Developments
- 6.10 Institutional Pharmacy Solutions
- 6.10.1 Institutional Pharmacy Solutions Company Information
- 6.10.2 Institutional Pharmacy Solutions Business Overview
- 6.10.3 Institutional Pharmacy Solutions Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio
- 6.10.5 Institutional Pharmacy Solutions Recent Developments
- 6.11 Fresenius Kabi
- 6.11.1 Fresenius Kabi Company Information
- 6.11.2 Fresenius Kabi Business Overview
- 6.11.3 Fresenius Kabi Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Fresenius Kabi Compounded Topical Drug Product Portfolio
- 6.11.5 Fresenius Kabi Recent Developments
- 6.12 Fagron
- 6.12.1 Fagron Company Information
- 6.12.2 Fagron Business Overview
- 6.12.3 Fagron Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Fagron Compounded Topical Drug Product Portfolio
- 6.12.5 Fagron Recent Developments
- 6.13 Custom Scripts Pharmacy
- 6.13.1 Custom Scripts Pharmacy Company Information
- 6.13.2 Custom Scripts Pharmacy Business Overview
- 6.13.3 Custom Scripts Pharmacy Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio
- 6.13.5 Custom Scripts Pharmacy Recent Developments
- 6.14 Central Admixture Pharmacy Services (CAPS)
- 6.14.1 Central Admixture Pharmacy Services (CAPS) Company Information
- 6.14.2 Central Admixture Pharmacy Services (CAPS) Business Overview
- 6.14.3 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio
- 6.14.5 Central Admixture Pharmacy Services (CAPS) Recent Developments
- 6.15 CareFirst Specialty Pharmacy
- 6.15.1 CareFirst Specialty Pharmacy Company Information
- 6.15.2 CareFirst Specialty Pharmacy Business Overview
- 6.15.3 CareFirst Specialty Pharmacy Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio
- 6.15.5 CareFirst Specialty Pharmacy Recent Developments
- 6.16 Cantrell Drug Company
- 6.16.1 Cantrell Drug Company Company Information
- 6.16.2 Cantrell Drug Company Business Overview
- 6.16.3 Cantrell Drug Company Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Cantrell Drug Company Compounded Topical Drug Product Portfolio
- 6.16.5 Cantrell Drug Company Recent Developments
- 6.17 B. Braun Melsungen AG Company
- 6.17.1 B. Braun Melsungen AG Company Company Information
- 6.17.2 B. Braun Melsungen AG Company Business Overview
- 6.17.3 B. Braun Melsungen AG Company Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio
- 6.17.5 B. Braun Melsungen AG Company Recent Developments
- 6.18 Avella Specialty Pharmacy
- 6.18.1 Avella Specialty Pharmacy Company Information
- 6.18.2 Avella Specialty Pharmacy Business Overview
- 6.18.3 Avella Specialty Pharmacy Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio
- 6.18.5 Avella Specialty Pharmacy Recent Developments
- 6.19 Atlas Pharmaceuticals
- 6.19.1 Atlas Pharmaceuticals Company Information
- 6.19.2 Atlas Pharmaceuticals Business Overview
- 6.19.3 Atlas Pharmaceuticals Compounded Topical Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio
- 6.19.5 Atlas Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Compounded Topical Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Compounded Topical Drug Market Size by Country (2021-2026)
- 7.3 North America Compounded Topical Drug Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Compounded Topical Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Compounded Topical Drug Market Size by Country (2021-2026)
- 8.3 Europe Compounded Topical Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Compounded Topical Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Compounded Topical Drug Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Compounded Topical Drug Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Compounded Topical Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Compounded Topical Drug Market Size by Country (2021-2026)
- 10.3 South America Compounded Topical Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Compounded Topical Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Compounded Topical Drug Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Compounded Topical Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst